The European Society for Medical Oncology (ESMO) has honored three of Europe's leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.
"The eminent oncologists we are celebrating with these awards have each made enormous contributions to the care of patients with cancer," said Prof David Kerr, ESMO President. "We congratulate them and thank them for their unstinting efforts on behalf of others."
The 2011 ESMO Award has been granted to Prof Johann de Bono of The Institute of Cancer Research and The Royal Marsden's Hospital in the UK, for his outstanding contributions in translational and clinical research, innovative treatment, education and development of international guidelines for prostate cancer management.
"Prof de Bono has undertaken exceptional work in the development of a number of new innovative compounds for several new indications in oncology and has made important contributions to the development of new drugs in prostate cancer, particularly through excellence in translational research and study design," said Dr Josep Tabernero, Chair of the ESMO Fellowship and Award Committee.
The ESMO Award is conferred on an ESMO member who has made an outstanding contribution to the development of oncology in Europe and who recognizes the importance of promoting oncology as a specialty within the international community.
"This award is a great encouragement and will spur me on to continue to serve cancer patients," Prof de Bono said. "Drug development in oncology has made substantial strides forward over the last decade. While much still needs to be done, we can now be confident that much will be accomplished in the years ahead."
The Hamilton Fairley Award for 2011 has been awarded to Prof Rafael Rosell of the Catalan Institute of Oncology in Badalona, Spain. Prof Rosell is a leading figure in the field of lung cancer, who established a productive
|Contact: Vanessa Pavinato|
European Society for Medical Oncology